Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel
FDA 510(k) clearance K241806 · decided 2025-01-08
Clearance details
- K-number
- K241806
- Device name
- Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel
- Applicant
- Life Technologies Corporation
- Decision
- Substantially Equivalent
- Date received
- 2024-06-21
- Decision date
- 2025-01-08
- Days to decision
- 201 days
- Clearance type
- Traditional
- Product code
- QOF
- Device class
- 2
- Regulation number
- 866.3981
- Medical specialty
- Microbiology
- Advisory committee
- Microbiology
- Location
- Pleasanton,, CA, US
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch Life Technologies Corporation
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Similar devices under this product code
Devices cleared under the same product code - the starting set for predicate research.
Recalls involving this device
No recalls on record reference this clearance.
PMA approvals by this applicant
| Record | Firm | Date |
|---|---|---|
| Oncomine Dx Target Test (P160045/S051) | Life Technologies Corporation | 2025-11-21 |
| Oncomine Dx Target Test (P160045/S050) | Life Technologies Corporation | 2025-11-19 |
| Oncomine Dx Express Test (P240040/S003) | Life Technologies Corporation | 2025-10-22 |
| Oncomine Dx Express Test (P240040/S002) | Life Technologies Corporation | 2025-10-15 |
| Oncomine Dx Target Test (P160045/S049) | Life Technologies Corporation | 2025-08-08 |
| Oncomine Dx Express Test (P240040/S001) | Life Technologies Corporation | 2025-08-07 |
| Oncomine Dx Express Test (P240040) | Life Technologies Corporation | 2025-07-02 |
| Oncomine Dx Target Test (P160045/S046) | Life Technologies Corporation | 2024-10-17 |